ImmuPharma PLC

ImmuPharma PLC
Stock Exchange London Stock Exchange
EPS
GBP0.05
Market Cap
GBP14.71 M
Shares Outstanding
139.47 M
Public Float
102.98 M

Profile

Address
50 Broadway
London Greater London SW1 H0RG
United Kingdom
Employees -
Website http://www.immupharma.com
Updated 07/08/2019
ImmuPharma Plc engages in the research, development, and commercialisation of pharmaceutical products. Its drug candidate, Lupuzor, is a potential treatment for the autoimmune chronic inflammatory disease lupus. The company was founded by Richard Warr and Dimitri F.

Financials

View All
Created with Highcharts 5.0.14ImmuPharma PLCNet Income. Fiscal year is January-December. All values GBP Thousands.3 6893 6892 8712 8713 8973 8975 3245 3246 2236 2237 2067 20620132014201520162017201802k4k6k8k
Created with Highcharts 5.0.14ImmuPharma PLCSales/Revenue. Fiscal year is January-December. All values GBP Thousands.0018418476761641641501508181201320142015201620172018050100150200

Dimitri F. Dimitriou
Chief Executive Officer & Director
Robert Henri Zimmer
President, Director & Chief Scientific Officer